...
【24h】

The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration.

机译:局部透明质酸在复发性口疮溃疡治疗中的功效。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to evaluate the efficacy of a topical hyaluronic acid (HA) preparation (0.2%) in the management of recurrent aphthous ulceration (RAU). One hundred and twenty patients with RAU participated in a randomized, placebo controlled, double-blind trial to evaluate the efficacy of the topical HA and preparation. Outcome measures include soreness relief on immediate application (recorded over 60 min). Thereafter, patients completed a log diary recording soreness from the ulcers, occurrence of new ulcers and ulcer duration. Both topical HA and placebo resulted in a significant reduction in ulcer soreness following immediate application (P = 0.0004). Throughout the rest of the investigation period, there was no significant differences (P > 0.05) between the treatments for reducing soreness. Patients treated with topical HA recorded few ulcers on day 5 of the investigation than those treated with placebo (P < 0.001). Likewise, the occurrence of new ulcers was lower in the HA treated groupon day 4 when compared with placebo (P = 0.047). Topical HA (0.2%) may be of benefit in the management of RAU. Immediate reduction of symptoms appears to be a barrier effect.
机译:这项研究的目的是评估局部透明质酸(HA)制剂(0.2%)在治疗复发性口疮(RAU)中的功效。 120名RAU患者参加了一项随机,安慰剂对照,双盲试验,以评估局部用HA和制剂的疗效。结果措施包括立即应用缓解疼痛(记录60分钟以上)。此后,患者完成了日志记录,记录了溃疡的疼痛感,新溃疡的发生和溃疡持续时间。立即应用后,局部用HA和安慰剂均可显着减少溃疡性溃疡(P = 0.0004)。在整个研究期间的其余时间内,减轻疼痛的治疗之间没有显着差异(P> 0.05)。在研究的第5天,局部用HA治疗的患者比用安慰剂治疗的患者记录的溃疡少(P <0.001)。同样,与安慰剂相比,HA治疗组在第4天新发溃疡的发生率更低(P = 0.047)。外用HA(0.2%)可能对RAU的治疗有益。立即减轻症状似乎是一种屏障作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号